Innovent Biologics, Inc. carries a market capitalization of 21.27B, placing it among publicly traded companies globally.
| Market Cap | 21.27B |
| Enterprise Value | N/A |
Innovent Biologics, Inc.'s stock has gained approximately 5.31952% over the past 52 weeks. The 50-day moving average sits at 12.60, while the 200-day moving average is 11.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 5.31952% |
| 50-Day Moving Average | 12.60 |
| 200-Day Moving Average | 11.23 |
| Average Volume (20 Days) | N/A |
Already premium?